Why Lilly?

At Lilly, we believe our people are the source of all our successes. Our future depends on our global community of employees whose varied perspectives, experiences and skills fuel the creativity for pharmaceutical innovation.

Lilly has major research and development facilities in nine countries and conducts clinical trials in more than 50 countries globally – all in support of developing and producing the medicines that help improve lives around the world.

Not only have we been globally acclaimed as one of the top 500 companies to work for by Fortune magazine, Lilly UK has received recognition for the following:

  • Winners of the Reputation Award given by the Chemical Industries Association in 2012 for our UK Manufacturing site, Speke.
  • Awarded Company of the Year by the Chemical Industries Association in 2012 for our UK manufacturing site at Speke.
  • Awarded the Carbon Trust Standard in 2011 in recognition of our carbon management programmes – Lilly was one of the first major pharmaceutical companies to achieve this standard in 2009.
  • Since 2010 we have consistently held the National Association of Pension Funds, Pension Quality Mark “Plus” award which reflects governance, communication, investment and employer contributions.

These achievements would not have been possible without our employees' continued commitment to our core values – respect for people, integrity and excellence.


Learn more about Lilly's R&D


Learn more about our UK business